(2022). Comparative risk of acute myocardial infarction for anti-osteoporosis drugs in primary care: a meta-analysis of propensity-matched cohort findings from the UK Clinical Practice Research Database and the Catalan SIDIAP Database. Osteoporos Int. http://doi.org/10.1007/s00198-021-06262-1.
(2011). Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. Bmj. http://doi.org/10.1136/bmj.d7222.
(2011). Changes in hip fracture rate before and after total knee replacement due to osteoarthritis: a population-based cohort study. Ann Rheum Dis. http://doi.org/10.1136/ard.2010.131110.
(2011). Fracture risk before and after total hip replacement in patients with osteoarthritis: potential benefits of bisphosphonate use. Arthritis Rheum. http://doi.org/10.1002/art.30214.
(2012). The lifetime risk of total hip and knee arthroplasty: results from the UK general practice research database. Osteoarthritis Cartilage. http://doi.org/10.1016/j.joca.2012.02.636.
(2013). Fracture rate in patients with myasthenia gravis: the general practice research database. Osteoporos Int. http://doi.org/10.1007/s00198-012-1970-5.
(2015). Hormone replacement therapy and mid-term implant survival following knee or hip arthroplasty for osteoarthritis: a population-based cohort study. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2013-204043.
(2016). Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis. J Bone Miner Res. http://doi.org/10.1002/jbmr.2882.
(2017). Geographic variation in secondary fracture prevention after a hip fracture during 1999-2013: a UK study. Osteoporos Int. http://doi.org/10.1007/s00198-016-3811-4.
(2017). Cost-Effectiveness of Orthogeriatric and Fracture Liaison Service Models of Care for Hip Fracture Patients: A Population-Based Study. J Bone Miner Res. http://doi.org/10.1002/jbmr.2995.